For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of this treatment and Attruby represents a true advancement . These groundbreaking therapies stabilize the transthyretin protein, halting its destructive build-up and lessening the impact of the condition . Patients are now experiencing im